|
|
||||||||
Department of Pharmacology, University of Medicine and Dentistry of New JerseyRobert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
(RECEIVED April 5, 2004; FINAL REVISION May 10, 2004; ACCEPTED May 18, 2004)
The preponderance of evidence implicates protein misfolding in many unrelated human diseases. In all cases, normal correctly folded proteins transform from their proper native structure into an abnormal
-rich structure known as amyloid fibril. Here we introduce a computational algorithm to detect nonnative (hidden) sequence propensity for amyloid fibril formation. Analyzing sequencestructure relationships in terms of tertiary contact (TC), we find that the hidden
-strand propensity of a query local sequence can be quantitatively estimated from the secondary structure preferences of template sequences of known secondary structure found in regions of high TC. The present method correctly pinpoints the minimal peptide fragment shown experimentally as the likely local mediator of amyloid fibril formation in
-amyloid peptide, islet amyloid polypeptide (hIAPP),
-synuclein, and human acetylcholinesterase (AChE). It also found previously unrecognized
-strand propensities in the prototypical helical protein myoglobin that has been reported as amyloidogenic. Analysis of 2358 nonhomologous protein domains provides compelling evidence that most proteins contain sequences with significant hidden
-strand propensity. The present method may find utility in many medically relevant applications, such as the engineering of protein sequences and the discovery of therapeutic agents that specifically target these sequences for the prevention and treatment of amyloid diseases.
Keywords: amyloid fibril; tertiary contacts; secondary structure; hidden
-strand propensity; H
P, SCOP
Abbreviations: A
,
-amyloid AchE, human acetylcholinesterase ANN, artificial neural network BuChE, butyrylcholinesterase DSSP, definition of secondary structure of proteins H
P, hidden
propensity HIAPP, human islet amyloid precursor protein NAC, non-A
component of Alzheimers disease amyloid PAM, percentage accepted mutations PDB, Protein Data Bank SCOP, structural classification of proteins TC, tertiary contact.
Reprint requests to: William J. Welsh, Department of Pharmacology, University of Medicine & Dentistry of New JerseyRobert Wood Johnson Medical School, Piscataway, NJ 08854, USA; e-mail: welshwj{at}umdnj.edu; fax: (732) 235-3475.
1 Present address: ArQule, Inc., Woburn, MA 01801, USA.
Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.04790604.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Z. Zhang, H. Chen, and L. Lai Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential Bioinformatics, September 1, 2007; 23(17): 2218 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang and J. Robbins Heart Failure and Protein Quality Control Circ. Res., December 8, 2006; 99(12): 1315 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Thompson, S. A. Sievers, J. Karanicolas, M. I. Ivanova, D. Baker, and D. Eisenberg The 3D profile method for identifying fibril-forming segments of proteins. PNAS, March 14, 2006; 103(11): 4074 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, S. Yoon, and W. J. Welsh Improved method for predicting {beta}-turn using support vector machine Bioinformatics, May 15, 2005; 21(10): 2370 - 2374. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |